Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Orphanet Journal of Rare Diseases
|
July 6, 2023
Caregiver burden in Bardet-Biedl syndrome: findings from the CARE-BBS study
Elizabeth Forsythe, Usha G Mallya, Min Yang, et al.
Orphanet Journal of Rare Diseases
|
July 6, 2023
Burden of hyperphagia and obesity in Bardet-Biedl syndrome: a multicountry survey
Elizabeth Forsythe, Usha G Mallya, Min Yang, et al.
The Journal of Urology
|
April 18, 2007
Identification of a recurrent t(4;6) chromosomal translocation in prostate cancer
Tim M Lane, Jon C Strefford, Rafael J Yáñez-Muñoz, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 7, 2025
Impact of Setmelanotide on Metabolic Syndrome Risk in Patients With Bardet-Biedl Syndrome
Andrea M Haqq, Christine Poitou, Wendy K Chung, et al.
EMBO Reports
|
January 11, 2021
Bardet-Biedl Syndrome ciliopathy is linked to altered hematopoiesis and dysregulated self-tolerance
Oksana Tsyklauri, Veronika Niederlova, Elizabeth Forsythe, et al.
Orphanet Journal of Rare Diseases
|
January 16, 2023
Quality of life improvements following one year of setmelanotide in children and adult patients with Bardet-Biedl syndrome: phase 3 trial results
Elizabeth Forsythe, Robert M Haws, Jesús Argente, et al.
Journal of the American Society of Nephrology : JASN
|
September 24, 2016
Risk Factors for Severe Renal Disease in Bardet-Biedl Syndrome
Elizabeth Forsythe, Kathryn Sparks, Sunayna Best, et al.
The Lancet. Diabetes & Endocrinology
|
November 10, 2022
Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period
Andrea M Haqq, Wendy K Chung, Hélène Dollfus, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 27, 2026
Endocrine Characteristics in Bardet Biedl Syndrome from a Large Single-Centre Paediatric Multidisciplinary Clinic
Rachel S Varughese, Divya Pujari, Elizabeth Hatton, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 7, 2018
The Endocrine and Metabolic Characteristics of a Large Bardet-Biedl Syndrome Clinic Population
Safa Mujahid, Katharine F Hunt, Yee S Cheah, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Orphanet Journal of Rare Diseases
|
July 6, 2023
Caregiver burden in Bardet-Biedl syndrome: findings from the CARE-BBS study
Elizabeth Forsythe, Usha G Mallya, Min Yang, et al.
Orphanet Journal of Rare Diseases
|
July 6, 2023
Burden of hyperphagia and obesity in Bardet-Biedl syndrome: a multicountry survey
Elizabeth Forsythe, Usha G Mallya, Min Yang, et al.
The Journal of Urology
|
April 18, 2007
Identification of a recurrent t(4;6) chromosomal translocation in prostate cancer
Tim M Lane, Jon C Strefford, Rafael J Yáñez-Muñoz, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 7, 2025
Impact of Setmelanotide on Metabolic Syndrome Risk in Patients With Bardet-Biedl Syndrome
Andrea M Haqq, Christine Poitou, Wendy K Chung, et al.
EMBO Reports
|
January 11, 2021
Bardet-Biedl Syndrome ciliopathy is linked to altered hematopoiesis and dysregulated self-tolerance
Oksana Tsyklauri, Veronika Niederlova, Elizabeth Forsythe, et al.
Orphanet Journal of Rare Diseases
|
January 16, 2023
Quality of life improvements following one year of setmelanotide in children and adult patients with Bardet-Biedl syndrome: phase 3 trial results
Elizabeth Forsythe, Robert M Haws, Jesús Argente, et al.
Journal of the American Society of Nephrology : JASN
|
September 24, 2016
Risk Factors for Severe Renal Disease in Bardet-Biedl Syndrome
Elizabeth Forsythe, Kathryn Sparks, Sunayna Best, et al.
The Lancet. Diabetes & Endocrinology
|
November 10, 2022
Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period
Andrea M Haqq, Wendy K Chung, Hélène Dollfus, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 27, 2026
Endocrine Characteristics in Bardet Biedl Syndrome from a Large Single-Centre Paediatric Multidisciplinary Clinic
Rachel S Varughese, Divya Pujari, Elizabeth Hatton, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 7, 2018
The Endocrine and Metabolic Characteristics of a Large Bardet-Biedl Syndrome Clinic Population
Safa Mujahid, Katharine F Hunt, Yee S Cheah, et al.
Page
of 3